156 related articles for article (PubMed ID: 21353348)
21. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
Mallié M; Bastide JM; Blancard A; Bonnin A; Bretagne S; Cambon M; Chandenier J; Chauveau V; Couprie B; Datry A; Feuilhade M; Grillot R; Guiguen C; Lavarde V; Letscher V; Linas MD; Michel A; Morin O; Paugam A; Piens MA; Raberin H; Tissot E; Toubas D; Wade A
Int J Antimicrob Agents; 2005 Apr; 25(4):321-8. PubMed ID: 15784312
[TBL] [Abstract][Full Text] [Related]
22. Copper(II) complexes with 2-pyridineformamide-derived thiosemicarbazones: spectral studies and toxicity against Artemia salina.
Ferraz KO; Wardell SM; Wardell JL; Louro SR; Beraldo H
Spectrochim Acta A Mol Biomol Spectrosc; 2009 Jul; 73(1):140-5. PubMed ID: 19286418
[TBL] [Abstract][Full Text] [Related]
23. In vitro activities of isavuconazole and other antifungal agents against Candida bloodstream isolates.
Seifert H; Aurbach U; Stefanik D; Cornely O
Antimicrob Agents Chemother; 2007 May; 51(5):1818-21. PubMed ID: 17307977
[TBL] [Abstract][Full Text] [Related]
24. Novel broad-spectrum metal-based antifungal agents. Correlations amongst the structural and biological properties of copper (II) 2-acetylpyridine N4-dialkylthiosemicarbazones.
Kumbhar AS; Padhye SB; Saraf AP; Mahajan HB; Chopade BA; West DX
Biol Met; 1991; 4(3):141-3. PubMed ID: 1931432
[TBL] [Abstract][Full Text] [Related]
25. Novel pyridobenzimidazole derivatives exhibiting antifungal activity by the inhibition of beta-1,6-glucan synthesis.
Takeshita H; Watanabe J; Kimura Y; Kawakami K; Takahashi H; Takemura M; Kitamura A; Someya K; Nakajima R
Bioorg Med Chem Lett; 2010 Jul; 20(13):3893-6. PubMed ID: 20605446
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, characterization and antimicrobial activity of Fe(II), Zn(II), Cd(II) and Hg(II) complexes with 2,6-bis(benzimidazol-2-yl) pyridine ligand.
Aghatabay NM; Neshat A; Karabiyik T; Somer M; Haciu D; Dülger B
Eur J Med Chem; 2007 Feb; 42(2):205-13. PubMed ID: 17189664
[TBL] [Abstract][Full Text] [Related]
27. [Antifungal effect of high molecular weight chitosan on Candida spp isolated from clinical samples].
Tapia CP; Soto DM; Vergara LG; Alburquerque CO; Maccioni AR; Matamata AM; Hermosilla GD; Bucarey SV
Rev Chilena Infectol; 2009 Dec; 26(6):515-9. PubMed ID: 20098785
[TBL] [Abstract][Full Text] [Related]
28. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
Takakura S; Fujihara N; Saito T; Kudo T; Iinuma Y; Ichiyama S
J Antimicrob Chemother; 2004 Feb; 53(2):283-9. PubMed ID: 14688039
[TBL] [Abstract][Full Text] [Related]
29. Optically active antifungal azoles: synthesis and antifungal activity of (2R,3S)-2-(2,4-difluorophenyl)-3-(5-[2-[4-aryl-piperazin-1-yl]-ethyl]-tetrazol-2-yl/1-yl)-1-[1,2,4]-triazol-1-yl-butan-2-ol.
Upadhayaya RS; Sinha N; Jain S; Kishore N; Chandra R; Arora SK
Bioorg Med Chem; 2004 May; 12(9):2225-38. PubMed ID: 15080922
[TBL] [Abstract][Full Text] [Related]
30. Bismuth heterocycles based on a diphenyl sulfone scaffold: synthesis and substituent effect on the antifungal activity against Saccharomyces cerevisiae.
Murafuji T; Fujiwara Y; Yoshimatsu D; Miyakawa I; Migita K; Mikata Y
Eur J Med Chem; 2011 Feb; 46(2):519-25. PubMed ID: 21177000
[TBL] [Abstract][Full Text] [Related]
31. In vitro activity of essential oils extracted from plants used as spices against fluconazole-resistant and fluconazole-susceptible Candida spp.
Pozzatti P; Scheid LA; Spader TB; Atayde ML; Santurio JM; Alves SH
Can J Microbiol; 2008 Nov; 54(11):950-6. PubMed ID: 18997851
[TBL] [Abstract][Full Text] [Related]
32. Mn(II), Co(II) and Zn(II) complexes with heterocyclic substituted thiosemicarbazones: synthesis, characterization, X-ray crystal structures and antitumor comparison.
Li MX; Chen CL; Zhang D; Niu JY; Ji BS
Eur J Med Chem; 2010 Jul; 45(7):3169-77. PubMed ID: 20434816
[TBL] [Abstract][Full Text] [Related]
33. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
Messer SA; Diekema DJ; Boyken L; Tendolkar S; Hollis RJ; Pfaller MA
J Clin Microbiol; 2006 Feb; 44(2):324-6. PubMed ID: 16455878
[TBL] [Abstract][Full Text] [Related]
34. Antifungal activity of black tea polyphenols (catechins and theaflavins) against Candida species.
Sitheeque MA; Panagoda GJ; Yau J; Amarakoon AM; Udagama UR; Samaranayake LP
Chemotherapy; 2009; 55(3):189-96. PubMed ID: 19420933
[TBL] [Abstract][Full Text] [Related]
35. Gold(I) derived thiosemicarbazone complexes with rare halogen-halogen interaction-reduction of [Au(damp-C1,N)Cl2].
Khanye SD; Báthori NB; Smith GS; Chibale K
Dalton Trans; 2010 Mar; 39(10):2697-700. PubMed ID: 20179866
[TBL] [Abstract][Full Text] [Related]
36. [Comparison of two different methods for the investigation of in vitro susceptibilities of planktonic and biofilm forming Candida species to antifungal agents].
Kaynak Onurdağ F; Ozgen S; Abbasoğlu U; Gürcan IS
Mikrobiyol Bul; 2010 Oct; 44(4):619-31. PubMed ID: 21063974
[TBL] [Abstract][Full Text] [Related]
37. Preparation of some pyrazoline derivatives and evaluation of their antifungal activities.
Ozdemir A; Turan-Zitouni G; Kaplancikli ZA; Revial G; Demirci F; Işcan G
J Enzyme Inhib Med Chem; 2010 Aug; 25(4):565-71. PubMed ID: 20205628
[TBL] [Abstract][Full Text] [Related]
38. In vitro anticandidal evaluation of novel highly functionalized bis cyclohexenone ethyl carboxylates.
Kanagarajan V; Ezhilarasi MR; Bhakiaraj D; Gopalakrishnan M
Eur Rev Med Pharmacol Sci; 2013 Feb; 17(3):292-8. PubMed ID: 23426531
[TBL] [Abstract][Full Text] [Related]
39. Antimony(III) complexes with 2-benzoylpyridine-derived thiosemicarbazones: cytotoxicity against human leukemia cell lines.
Reis DC; Pinto MC; Souza-Fagundes EM; Wardell SM; Wardell JL; Beraldo H
Eur J Med Chem; 2010 Sep; 45(9):3904-10. PubMed ID: 20576328
[TBL] [Abstract][Full Text] [Related]
40. [Antifungal susceptibility of Candida spp. isolates from blood cultures in a five-year period (1997-2001)].
Durán MT; Velasco D; Canle D; Moure R; Villanueva R
Enferm Infecc Microbiol Clin; 2003 Nov; 21(9):488-92. PubMed ID: 14572381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
